Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Structural basis for distinctive recognition of fibrinogen gammaC peptide by the platelet integrin alphaIIbbeta3.

Springer TA, Zhu J, Xiao T.

J Cell Biol. 2008 Aug 25;182(4):791-800. doi: 10.1083/jcb.200801146.

2.

[Structure-functional analysis of peptide P3 identical to gamma370-383 binding sites with integrin alphaIIbbeta3 in gammaC-domain of fibrinogen].

Podol'nikova NP, Volkov HL, Uharova TP.

Ukr Biokhim Zh (1999). 2003 Nov-Dec;75(6):99-105. Ukrainian.

PMID:
15143525
4.

Mapping the binding domains of the alpha(IIb) subunit. A study performed on the activated form of the platelet integrin alpha(IIb)beta(3).

Biris N, Abatzis M, Mitsios JV, Sakarellos-Daitsiotis M, Sakarellos C, Tsoukatos D, Tselepis AD, Michalis L, Sideris D, Konidou G, Soteriadou K, Tsikaris V.

Eur J Biochem. 2003 Sep;270(18):3760-7.

5.

A cluster of basic amino acid residues in the gamma370-381 sequence of fibrinogen comprises a binding site for platelet integrin alpha(IIb)beta3 (glycoprotein IIb/IIIa).

Podolnikova NP, Gorkun OV, Loreth RM, Yee VC, Lord ST, Ugarova TP.

Biochemistry. 2005 Dec 27;44(51):16920-30.

PMID:
16363805
6.

Structure-guided design of a high-affinity platelet integrin αIIbβ3 receptor antagonist that disrupts Mg²⁺ binding to the MIDAS.

Zhu J, Choi WS, McCoy JG, Negri A, Zhu J, Naini S, Li J, Shen M, Huang W, Bougie D, Rasmussen M, Aster R, Thomas CJ, Filizola M, Springer TA, Coller BS.

Sci Transl Med. 2012 Mar 14;4(125):125ra32. doi: 10.1126/scitranslmed.3003576.

7.
8.

Ligands "activate" integrin alpha IIb beta 3 (platelet GPIIb-IIIa).

Du XP, Plow EF, Frelinger AL 3rd, O'Toole TE, Loftus JC, Ginsberg MH.

Cell. 1991 May 3;65(3):409-16.

PMID:
2018974
9.
10.

Identification of a novel binding site for platelet integrins alpha IIb beta 3 (GPIIbIIIa) and alpha 5 beta 1 in the gamma C-domain of fibrinogen.

Podolnikova NP, Yakubenko VP, Volkov GL, Plow EF, Ugarova TP.

J Biol Chem. 2003 Aug 22;278(34):32251-8.

12.
14.

Selection and structure of ion-selective ligands for platelet integrin alpha IIb(beta) 3.

Smith JW, Le Calvez H, Parra-Gessert L, Preece NE, Jia X, Assa-Munt N.

J Biol Chem. 2002 Mar 22;277(12):10298-305.

15.

Closed headpiece of integrin αIIbβ3 and its complex with an αIIbβ3-specific antagonist that does not induce opening.

Zhu J, Zhu J, Negri A, Provasi D, Filizola M, Coller BS, Springer TA.

Blood. 2010 Dec 2;116(23):5050-9. doi: 10.1182/blood-2010-04-281154.

16.

AlphaIIbbeta3 priming and clustering by orally active and intravenous integrin antagonists.

Hantgan RR, Stahle MC, Connor JH, Connor RF, Mousa SA.

J Thromb Haemost. 2007 Mar;5(3):542-50.

17.
18.

β-Subunit Binding Is Sufficient for Ligands to Open the Integrin αIIbβ3 Headpiece.

Lin FY, Zhu J, Eng ET, Hudson NE, Springer TA.

J Biol Chem. 2016 Feb 26;291(9):4537-46. doi: 10.1074/jbc.M115.705624.

19.

The interaction of integrin αIIbβ3 with fibrin occurs through multiple binding sites in the αIIb β-propeller domain.

Podolnikova NP, Yakovlev S, Yakubenko VP, Wang X, Gorkun OV, Ugarova TP.

J Biol Chem. 2014 Jan 24;289(4):2371-83. doi: 10.1074/jbc.M113.518126.

20.

RGD-containing peptides inhibit fibrinogen binding to platelet alpha(IIb)beta3 by inducing an allosteric change in the amino-terminal portion of alpha(IIb).

Basani RB, D'Andrea G, Mitra N, Vilaire G, Richberg M, Kowalska MA, Bennett JS, Poncz M.

J Biol Chem. 2001 Apr 27;276(17):13975-81.

Items per page

Supplemental Content

Support Center